204 related articles for article (PubMed ID: 22241909)
1. Proof-of-concept study of monitoring cancer drug therapy with cerenkov luminescence imaging.
Xu Y; Chang E; Liu H; Jiang H; Gambhir SS; Cheng Z
J Nucl Med; 2012 Feb; 53(2):312-317. PubMed ID: 22241909
[TBL] [Abstract][Full Text] [Related]
2. Cerenkov Luminescence Imaging (CLI) for cancer therapy monitoring.
Xu Y; Liu H; Chang E; Jiang H; Cheng Z
J Vis Exp; 2012 Nov; (69):e4341. PubMed ID: 23183774
[TBL] [Abstract][Full Text] [Related]
3. Multimodal imaging with (18)F-FDG PET and Cerenkov luminescence imaging after MLN4924 treatment in a human lymphoma xenograft model.
Robertson R; Germanos MS; Manfredi MG; Smith PG; Silva MD
J Nucl Med; 2011 Nov; 52(11):1764-9. PubMed ID: 21994410
[TBL] [Abstract][Full Text] [Related]
4. Cerenkov Luminescence Imaging as a Modality to Evaluate Antibody-Based PET Radiotracers.
D'Souza JW; Hensley H; Doss M; Beigarten C; Torgov M; Olafsen T; Yu JQ; Robinson MK
J Nucl Med; 2017 Jan; 58(1):175-180. PubMed ID: 27539844
[TBL] [Abstract][Full Text] [Related]
5. Comparative immuno-Cerenkov luminescence and -PET imaging enables detection of PSMA
Maier FC; Wild AM; Kirchen N; Holm F; Fuchs K; Schwenck J; Maurer A; Wiehr S
Appl Radiat Isot; 2019 Jan; 143():149-155. PubMed ID: 30445280
[TBL] [Abstract][Full Text] [Related]
6. (68)Ga-labeled 3PRGD2 for dual PET and Cerenkov luminescence imaging of orthotopic human glioblastoma.
Fan D; Zhang X; Zhong L; Liu X; Sun Y; Zhao H; Jia B; Liu Z; Zhu Z; Shi J; Wang F
Bioconjug Chem; 2015 Jun; 26(6):1054-60. PubMed ID: 25853280
[TBL] [Abstract][Full Text] [Related]
7. Intratherapeutic biokinetic measurements, dosimetry parameter estimates, and monitoring of treatment efficacy using cerenkov luminescence imaging in preclinical radionuclide therapy.
Timmermand OV; Tran TA; Strand SE; Axelsson J
J Nucl Med; 2015 Mar; 56(3):444-9. PubMed ID: 25655628
[TBL] [Abstract][Full Text] [Related]
8. Cerenkov luminescence imaging of interscapular brown adipose tissue using a TSPO-targeting PET probe in the UCP1 ThermoMouse.
Lee SY; Oh HR; Kim YH; Bae SH; Lee Y; Lee YS; Lee BC; Cheon GJ; Kang KW; Youn H
Theranostics; 2022; 12(14):6380-6394. PubMed ID: 36168637
[No Abstract] [Full Text] [Related]
9. Cerenkov luminescence imaging of medical isotopes.
Ruggiero A; Holland JP; Lewis JS; Grimm J
J Nucl Med; 2010 Jul; 51(7):1123-30. PubMed ID: 20554722
[TBL] [Abstract][Full Text] [Related]
10. Intraoperative Assessment of Tumor Resection Margins in Breast-Conserving Surgery Using
Grootendorst MR; Cariati M; Pinder SE; Kothari A; Douek M; Kovacs T; Hamed H; Pawa A; Nimmo F; Owen J; Ramalingam V; Sethi S; Mistry S; Vyas K; Tuch DS; Britten A; Van Hemelrijck M; Cook GJ; Sibley-Allen C; Allen S; Purushotham A
J Nucl Med; 2017 Jun; 58(6):891-898. PubMed ID: 27932562
[TBL] [Abstract][Full Text] [Related]
11. Correlation between positron emission tomography and Cerenkov luminescence imaging in vivo and ex vivo using 64Cu-labeled antibodies in a neuroblastoma mouse model.
Maier FC; Schmitt J; Maurer A; Ehrlichmann W; Reischl G; Nikolaou K; Handgretinger R; Pichler BJ; Thaiss WM
Oncotarget; 2016 Oct; 7(41):67403-67411. PubMed ID: 27602580
[TBL] [Abstract][Full Text] [Related]
12. Intraoperative imaging of tumors using Cerenkov luminescence endoscopy: a feasibility experimental study.
Liu H; Carpenter CM; Jiang H; Pratx G; Sun C; Buchin MP; Gambhir SS; Xing L; Cheng Z
J Nucl Med; 2012 Oct; 53(10):1579-84. PubMed ID: 22904353
[TBL] [Abstract][Full Text] [Related]
13. In vivo optical imaging of interscapular brown adipose tissue with (18)F-FDG via Cerenkov luminescence imaging.
Zhang X; Kuo C; Moore A; Ran C
PLoS One; 2013; 8(4):e62007. PubMed ID: 23637947
[TBL] [Abstract][Full Text] [Related]
14. Cerenkov imaging.
Das S; Thorek DL; Grimm J
Adv Cancer Res; 2014; 124():213-34. PubMed ID: 25287690
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of 3'-deoxy-3'-18F-fluorothymidine uptake to cell proliferation in lung carcinoma xenografts].
Liu X; Zhou NK; Zhang JM; Liang ZY; Zheng X
Ai Zheng; 2006 Dec; 25(12):1512-6. PubMed ID: 17166377
[TBL] [Abstract][Full Text] [Related]
16. Intraoperative imaging of positron emission tomographic radiotracers using Cerenkov luminescence emissions.
Holland JP; Normand G; Ruggiero A; Lewis JS; Grimm J
Mol Imaging; 2011 Jun; 10(3):177-86, 1-3. PubMed ID: 21496448
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of 89Zr-rituximab tracer by Cerenkov luminescence imaging and correlation with PET in a humanized transgenic mouse model to image NHL.
Natarajan A; Habte F; Liu H; Sathirachinda A; Hu X; Cheng Z; Nagamine CM; Gambhir SS
Mol Imaging Biol; 2013 Aug; 15(4):468-75. PubMed ID: 23471750
[TBL] [Abstract][Full Text] [Related]
18. Early detection of response to experimental chemotherapeutic Top216 with [18F]FLT and [18F]FDG PET in human ovary cancer xenografts in mice.
Jensen MM; Erichsen KD; Björkling F; Madsen J; Jensen PB; Højgaard L; Sehested M; Kjær A
PLoS One; 2010 Sep; 5(9):e12965. PubMed ID: 20885974
[TBL] [Abstract][Full Text] [Related]
19. Prospective testing of clinical Cerenkov luminescence imaging against standard-of-care nuclear imaging for tumour location.
Pratt EC; Skubal M; Mc Larney B; Causa-Andrieu P; Das S; Sawan P; Araji A; Riedl C; Vyas K; Tuch D; Grimm J
Nat Biomed Eng; 2022 May; 6(5):559-568. PubMed ID: 35411113
[TBL] [Abstract][Full Text] [Related]
20. β-Radioluminescence Imaging: A Comparative Evaluation with Cerenkov Luminescence Imaging.
King MT; Carpenter CM; Sun C; Ma X; Le QT; Sunwoo JB; Cheng Z; Pratx G; Xing L
J Nucl Med; 2015 Sep; 56(9):1458-64. PubMed ID: 26205301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
